Shanghai Lung Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis1 trial
• Lung cancer1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Guangdong Raynovent Biotech Co., Ltd1 trial
• Jiangsu HengRui Medicine Co., Ltd.1 trial

Closed trials

• Completed

  Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）

  NCT05119972· Phase 1/2· Guangdong Raynovent Biotech Co., Ltd· Source

• Terminated

  A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

  NCT04619433· Phase 3· Jiangsu HengRui Medicine Co., Ltd.· Source